Maridebart cafraglutide Antibody

Maridebart cafraglutide is an antibody-peptide conjugate that functions as a dual GLP-1 receptor agonist and GIP receptor antagonist. It has demonstrated efficacy in reducing body weight and improving metabolic parameters in preclinical in vivo studies using obese male mice and cynomolgus monkeys, highlighting its utility for obesity and metabolic disease research.